Gelesis Holdings Past Earnings Performance
Past criteria checks 0/6
Gelesis Holdings's earnings have been declining at an average annual rate of -0.6%, while the Biotechs industry saw earnings growing at 17.4% annually. Revenues have been declining at an average rate of 45.8% per year.
Key information
-0.6%
Earnings growth rate
48.4%
EPS growth rate
| Biotechs Industry Growth | 17.0% |
| Revenue growth rate | -45.8% |
| Return on equity | n/a |
| Net Margin | -425.6% |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Gelesis Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 12 | -52 | 45 | 12 |
| 31 Mar 23 | 20 | -57 | 70 | 15 |
| 31 Dec 22 | 26 | -95 | 99 | 19 |
| 30 Sep 22 | 26 | -45 | 108 | 16 |
| 30 Jun 22 | 22 | -85 | 115 | 16 |
| 31 Mar 22 | 16 | -179 | 97 | 16 |
| 31 Dec 21 | 11 | -188 | 71 | 13 |
| 30 Sep 21 | 10 | -232 | 61 | 18 |
| 30 Jun 21 | 8 | -195 | 44 | 18 |
| 31 Mar 21 | 25 | -79 | 35 | 15 |
| 31 Dec 20 | 21 | -38 | 29 | 16 |
| 31 Dec 19 | 0 | -13 | 16 | 14 |
| 31 Dec 14 | 0 | -18 | 5 | 0 |
| 30 Sep 14 | 1 | -15 | 3 | 0 |
| 31 Dec 13 | 6 | 0 | 2 | 0 |
| 31 Dec 12 | 4 | -3 | 2 | 0 |
Quality Earnings: GLSH is currently unprofitable.
Growing Profit Margin: GLSH is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: GLSH is unprofitable, and losses have increased over the past 5 years at a rate of 0.6% per year.
Accelerating Growth: Unable to compare GLSH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: GLSH is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-42.7%).
Return on Equity
High ROE: GLSH's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.